Purpose: We sought to evaluate the visual measurements of coronary artery calcium (CAC) in chest CT without ECG gating, and to compare their predictive abilities for obstructive coronary artery disease (CAD). Methods: We analyzed 163 subjects who underwent both coronary and chest CT examinations at 6 centers within 3 months. Agatston scores were calculated on standard ECG-gated scans and then classified into none (0), mild (1–99), moderate (100–400), and severe (>400) grades. Chest CT images were reconstructed with standard 5.0 mm axial slices. CAC in chest CT scans was measured using two methods: Weston score (sum of the assigned score of each vessel, range: 0–12) and number of slices showing CAC (Ca-slice#). Results: We found excellent inter-observer agreement in the estimates of the Weston score and Ca-slice# (R² = 0.913 and 0.955, respectively). When each of the two scores was divided into four levels, good agreement with the 4-grade Agatston score was observed (kappa value = 0.604 and 0.794, respectively). Of the 155 patients remaining after excluding non-diagnostic studies, obstructed CAD, defined as the presence of ≥70% stenosis on CT angiography, was found in 43 (27%). Receiver-operator characteristic curves of 4-grade hierarchies of Agatston score, Weston score, and Ca-slice# provided similar diagnostic powers to detect obstructed CAD (0.722, 0.706, and 0.718, respectively).Conclusion: The visual assessments of CAC detected by ECG non-gated chest CT scans were in good agreement with the ECG-gated Agatston score and also provided equivalent power to detect obstructive CAD. This study was registered at UMIN-CTR (identifier: UMIN000039178; registered date; Jan 16, 2020)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.